Modulators of cellular adhesion
US8071617B2 · kind B2 · utility
2Cited by
28References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2011 |
| Grant date | Dec 6, 2011 |
| Priority date | — |
| Expiry date | Feb 4, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds having formula (I):and pharmaceutically acceptable derivatives thereof, wherein R1-R4, n, p, A, B, D, E, L and AR1 are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of disorders mediated by the CD11/CD18 family of cellular adhesion molecules (e.g., LFA-1).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.